Contact Details
- Phone
- 64 3 474 0999
- michael.schultz@otago.ac.nz
University Links
- Position
- Professor and Gastroenterologist
- Department
- Department of Medicine (Dunedin)
- Qualifications
- MD PhD
- Research summary
- Intestinal epithelial function in health and disease
- Teaching
- MICN2 and 3: SIS, Systems Integration Course (until 2008)
- MICN2/3: Clinical advisor in Gastroenterology to the Curriculum Development Group
- MICN3: Clinical Skills Tutor (since 2008)
- MICN4: clinical teaching and home tutoring, OSLERs, key topics
- MICN5: intercalated teaching, OSCE
- Station development in 2008
- Lead examiner for 2009
- MICN6: tutorials for trainee interns
- MICN5: Mentor, TPER
- Clinical
Inflammatory Bowel Disease
Research
Michael Schultz has a special interest in inflammatory bowel diseases and related disorders both on a clinical and basic research level. As director of the Gut Health Network, a research theme of the University of Otago, he is involved in a variety of projects. Basic science: The research group is located in the Department of Physiology in the laboratory of Associate Professor Grant Butt and works on the role of epithelium in intestinal inflammation with the use of human organoids, animal models and cell cultures. Collaborations with the Department of Microbiology and Immunology support these projects. Professor Schultz is involved in several epidemiological and therapeutic projects involving patients with irritable bowel syndrome, coeliac disease, and non-alcoholic fatty liver disease.
Publications
Amiesimaka, O. I., Allemann, S. S., Braund, R., Schultz, M., & Aluzaite, K. (2024). Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis. British Journal of Clinical Pharmacology. Advance online publication. doi: 10.1111/bcp.16069 Journal - Research Article
Amiesimaka, O. I., Aluzaite, K., Braund, R., & Schultz, M. (2024). Improving medication adherence levels in inflammatory bowel disease (IBD) patients: A narrative evidence-based review. Patient Preference & Adherence, 18, 905-916. doi: 10.2147/PPA.S383304 Journal - Research Other
Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., Begun, J., … Schultz, M., … Connor, S. J. (2024). Fistulising Crohn's Disease in a large Australasian cohort: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1129. doi: 10.1093/ecco-jcc/jjad212.1259 Conference Contribution - Published proceedings: Abstract
Barnett, M., Mcnamara, J., Wilson, W., Pipicella, J., Ghaly, S., Gearry, R., … Schultz, M., … Andrews, J. M. (2024). Dose escalated Ustekinumab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1012. doi: 10.1093/ecco-jcc/jjad212.1142 Conference Contribution - Published proceedings: Abstract
Alshiwanna, B., Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., … Schultz, M., … Andrews, J. M. (2024). Dose escalated Infliximab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1005. doi: 10.1093/ecco-jcc/jjad212.1135 Conference Contribution - Published proceedings: Abstract
2024
Journal - Research Article
Amiesimaka, O. I., Allemann, S. S., Braund, R., Schultz, M., & Aluzaite, K. (2024). Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis. British Journal of Clinical Pharmacology. Advance online publication. doi: 10.1111/bcp.16069
Amiesimaka, O. I., Aluzaite, K., Braund, R., & Schultz, M. (2024). Using electronic health records in analysing medication adherence in southern New Zealand patients with inflammatory bowel disease. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1588), 25-36. Retrieved from https://nzmj.org.nz/
Journal - Research Other
Amiesimaka, O. I., Aluzaite, K., Braund, R., & Schultz, M. (2024). Improving medication adherence levels in inflammatory bowel disease (IBD) patients: A narrative evidence-based review. Patient Preference & Adherence, 18, 905-916. doi: 10.2147/PPA.S383304
Conference Contribution - Published proceedings: Abstract
Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., Begun, J., … Schultz, M., … Connor, S. J. (2024). Fistulising Crohn's Disease in a large Australasian cohort: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1129. doi: 10.1093/ecco-jcc/jjad212.1259
Barnett, M., Mcnamara, J., Wilson, W., Pipicella, J., Ghaly, S., Gearry, R., … Schultz, M., … Andrews, J. M. (2024). Dose escalated Ustekinumab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1012. doi: 10.1093/ecco-jcc/jjad212.1142
Alshiwanna, B., Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., … Schultz, M., … Andrews, J. M. (2024). Dose escalated Infliximab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1005. doi: 10.1093/ecco-jcc/jjad212.1135
Mcnamara, J., Alshiwanna, B., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., … Schultz, M., … Connor, S. J. (2024). Dose escalated vedolizumab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P959. doi: 10.1093/ecco-jcc/jjad212.1089
Pipicella, J. L., McNamara, J., Wilson, W., Lynch, K., Walker, G., Begun, J., … Gearry, R., Schultz, M., … Connor, S. J. (2024). The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn's Colitis Cure (CCC) data insights program. Journal of Crohn's & Colitis, 18(Suppl. 1), P880. doi: 10.1093/ecco-jcc/jjad212.1010
Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., Williams, A., … Schultz, M., … Andrews, J. M. (2024). The burden of mental health disease in people with inflammatory bowel disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P462. doi: 10.1093/ecco-jcc/jjad212.0592
Mcnamara, J., Wilson, W., Pipicella, J., Ghaly, S., Gearry, R., Begun, J., … Schultz, M., … Connor, S. J. (2024). Variation of outcomes in inflammatory bowel disease at ten Australasian centres: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P286. doi: 10.1093/ecco-jcc/jjad212.0416
2023
Journal - Research Article
Amiesimaka, O. I., Aluzaite, K., Braund, R., & Schultz, M. (2023). “It's just like putting your socks on”: Patients' perspectives on inflammatory bowel disease medication adherence. Exploratory Research in Clinical & Social Pharmacy, 12, 100385. doi: 10.1016/j.rcsop.2023.100385
Peyrin-Biroulet, L., Allegretti, J. R., Rubin, D. T., Bressler, B., Germinaro, M., Huang, K.-H. G., … Schultz, M., … Zhan, Q. (2023). Guselkumab in patients with moderately to severely active ulcerative colitis: QUASAR Phase 2b Induction Study. Gastroenterology. Advance online publication. doi: 10.1053/j.gastro.2023.08.038
McCarthy, N. E., Schultz, M., & Wall, C. L. (2023). Current state of dietetic services for inflammatory bowel disease patients in New Zealand: An observational study. Nutrition & Dietetics, 80, 538-545. doi: 10.1111/1747-0080.12811
Du, P., Maharjan, A., Calder, S., Schultz, M., Schamberg, G., Gharibans, A., … Cakmak, Y. O. (2023). Transcutaneous auricular vagus nerve stimulation normalizes induced gastric myoelectrical dysrhythmias in controls assessed by body-surface gastric mapping. Neuromodulation. Advance online publication. doi: 10.1016/j.neurom.2023.02.078
Journal - Research Other
Amiesimaka, O. I., Braund, R., Aluzaite, K., & Schultz, M. (2023). Constraints on medication-based inflammatory bowel disease therapy in Aotearoa New Zealand: Why medication adherence is important. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1574), 82-89. Retrieved from https://journal.nzma.org.nz/
Conference Contribution - Published proceedings: Abstract
Cochrane, J. N., & Schultz, M. P. (2023). Annual incidence and phenotypic presentation of IBD in Otago New Zealand: A 25-year epidemiological analysis. In T. Milne, H. Harcombe, L. Burga, M. Anwar, M. Garelja, A. Middleton, D. C. Ribeiro, N. Fleming, K. Ogbuehi & A. Bahn (Eds.), Proceedings of the 265th Otago Medical School Research Society (OMSRS) Meeting: Summer Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Yap, J., Wall, C., Meredith-Jones, K., Iosua, E., Osborne, H., & Schultz, M. (2023). Inflammatory bowel disease exercise and diet habits (IBDeat) study: Chronic metabolic disease risk factors among IBD patients in New Zealand. Journal of Crohn's & Colitis, 17(Suppl. 1), (pp. i615-i616). doi: 10.1093/ecco-jcc/jjac190.0614
Conference Contribution - Verbal presentation and other Conference outputs
Ombasa, L., Miller, J. C., Ware, L., Abbotts-Holmes, H., Gearry, R. B., Bayer, S. B., Schultz, M., … Highton, A. J., Costello, R. M., Frampton, C. M. A., … Houghton, L. A., & Roy, N. C. (2023, August). Study of mānuka honey for digestive health (SOOTHE). Verbal presentation at the Kai mō Aotearoa Food Science Meeting [Queenstown Molecular Biology (QMB) Satellite], Queenstown, New Zealand.
2022
Journal - Research Article
Angus, H. C. K., Urbano, P. C. M., Laws, G. A., Fan, S., Gadeock, S., Schultz, M., … Highton, A. J., & Kemp, R. A. (2022). An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Clinical & Translational Immunology, 11, e1407. doi: 10.1002/cti2.1407
Khalilipour, B. S., Day, A. S., Kenrick, K., Schultz, M., & Aluzaite, K. (2022). Diagnostic delay in paediatric inflammatory bowel disease: A systematic investigation. Journal of Clinical Medicine, 11, 4161. doi: 10.3390/jcm11144161
Tham, J. E., Lynch, L., Laursen, S. B., Laine, L., Dalton, H. R., Ngu, J., … Schultz, M., … Stanley, A. J. (2022). International multicenter study comparing demographics, therapy and outcomes in bleeding from Mallory Weiss tears and peptic ulcers. Endoscopy International Open, 10(5), E653-E658. doi: 10.1055/a-1784-0655
Buerkle, K. S., Vernon-Roberts, A., Ho, C., Schultz, M., & Day, A. S. (2022). A short knowledge assessment tool is valid and acceptable for adults with inflammatory bowel disease. Digestive Diseases & Sciences, 67, 2049-2058. doi: 10.1007/s10620-022-07507-7
Urbano, P. C. M., Angus, H. C. K., Gadeock, S., Schultz, M., & Kemp, R. A. (2022). Assessment of source material for human intestinal organoid culture for research and clinical use. BMC Research Notes, 15, 35. doi: 10.1186/s13104-022-05925-4
Conference Contribution - Published proceedings: Abstract
Highton, A., Urbano, P., Fan, L., Laws, G., Schultz, M., & Kemp, R. (2022). Predicting anti-TNF responses in inflammatory bowel disease patients using intestinal organoids. Proceedings of the New Zealand Branch of the Australian and New Zealand Society for Immunology (NZASI) Conference. (pp. 34). Retrieved from https://nzasi2022.com/programme
Laws, G., Angus, H., Fan, L., Urbano, P., Highton, A., Schultz, M., & Kemp, R. (2022). Inflammatory T cells result in epithelial damage in patients with Crohn's disease. Proceedings of the New Zealand Branch of the Australian and New Zealand Society for Immunology (NZASI) Conference. (pp. 26). Retrieved from https://nzasi2022.com/programme
Conference Contribution - Verbal presentation and other Conference outputs
Schultz, M. (2022, November). IBDsmart: Monitoring a chronic disease remotely. Verbal presentation at the Bioengineering@Otago Showcase, [Online].
Yap, J., Wall, C., Meredith-Jones, K., Osborne, H., Iosua, E., & Schultz, M. (2022, September). New Zealand adults with inflammatory bowel disease exercise and diet (IBDeat) habits. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand.
Amiesimaka, O. I., Aluzaite, K., Braund, R., & Schultz, M. (2022, September). Patients' perspectives on inflammatory bowel disease medication adherence in Southern New Zealand. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand.
2021
Journal - Research Article
Aluzaite, K., Braund, R., Seeley, L., Amiesimaka, O. I., & Schultz, M. (2021). Adherence to inflammatory bowel disease medications in southern New Zealand. Crohn's & Colitis 360, 3(otab056). doi: 10.1093/crocol/otab056
Fraser-Miller, S. J., Rooney, J. S., Lau, M., Gordon, K. C., & Schultz, M. (2021). Can coupling multiple complementary methods improve the spectroscopic based diagnosis of gastrointestinal illnesses? A proof of principle ex vivo study using celiac disease as the model illness. Analytical Chemistry, 93, 6363-6374. doi: 10.1021/acs.analchem.0c04963
Fagan, G., Osborne, H., & Schultz, M. (2021). Physical activity in patients with inflammatory bowel disease: A cross-sectional study. Inflammatory Intestinal Diseases, 6, 61-69. doi: 10.1159/000511212
Appleton, K., Whittaker, E., Cohen, Z., Rhodes, H. M., Dunn, C., Murphy, S., Gaastra, M., Galletly, A., Dougherty, S., Haren, A., Sukumaran, N., Aluzaite, K., Dockerty, J. D., Turner, R. M., & Schultz, M. (2021). Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: An exploratory study. New Zealand Medical Journal, 134(1530), 38-47. Retrieved from https://www.nzma.org.nz/journal
Aluzaite, K., Wu, H., Hyslop, B., Young, J., Schultz, M., & Brockway, B. (2021). Perceived versus objective sleep quality in long-stay hospitalised older adults: A mixed methods study. Age & Ageing, 50, 955-962. doi: 10.1093/ageing/afaa292
Aluzaite, K., Greveson, K., Ben-Horin, S., Leong, R., & Schultz, M. (2021). Barriers to international travel in inflammatory bowel disease patients. Journal of Travel Medicine, 28(1), taaa197. doi: 10.1093/jtm/taaa197
Laursen, S. B., Oakland, K., Laine, L., Bieber, V., Marmo, R., Redondo-Cerezo, E., … Schultz, M., … Stanley, A. J. (2021). ABC score: A new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: An international multicentre study. Gut, 70, 707-716. doi: 10.1136/gutjnl-2019-320002
Conference Contribution - Published proceedings: Abstract
McCarthy, N. E., Schultz, M., & Wall, C. L. (2021). Access to dietetic services for inflammatory bowel disease patients in New Zealand: A patient view. New Zealand Medical Journal, 134(1537), (pp. 106). Retrieved from https://www.nzma.org.nz/journal
McCarthy, N., Schultz, M., & Wall, C. (2021). Nutrition and inflammatory bowel disease: A nationwide survey of patients, gastroenterologists and dietitians. Journal of Crohn's & Colitis, 15(Suppl. 1), (pp. S532-S533). doi: 10.1093/ecco-jcc/jjab076.696
2020
Journal - Research Article
Aluzaite, K., Fraser, M., Johnson, S., Giles, H., & Schultz, M. (2020). Successful use of generic direct acting antiviral medications to treat hepatitis C: A New Zealand-wide study. New Zealand Medical Journal, 133(1525), 53-61. Retrieved from https://www.nzma.org.nz/journal
Richard, L., Noller, G., Derrett, S., Sullivan, T., Doolan-Noble, F., McCombie, A., Schultz, M., Ho, C., & Stokes, T. (2020). Patients' accounts of living with and managing inflammatory bowel disease in rural Southern New Zealand: A qualitative study. BMJ Open, 10, e041789. doi: 10.1136/bmjopen-2020-041789
Stamm, R., Aluzaite, K., Arnold, M., Caspritz, T., White, C., & Schultz, M. (2020). Challenges for the future: The gastroenterology specialist workforce in New Zealand. New Zealand Medical Journal, 133(1519), 32-40. Retrieved from https://www.nzma.org.nz/journal
Aluzaite, K., Nuttall, J. W., O'Connor, M., Harvie, R., & Schultz, M. (2020). Quality of life in postostomy surgery patients: A cross-sectional survey. JGH Open, 4, 987-994. doi: 10.1002/jgh3.12383
Saffouri, E., Blackwell, C., Laursen, S. B., Laine, L., Dalton, H. R., Ngu, J., Schultz, M., … Stanley, A. J. (2020). The Shock Index is not accurate at predicting outcomes in patients with upper gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics, 51, 253-260. doi: 10.1111/apt.15541
McCombie, A., Walmsley, R., Barclay, M., Ho, C., Langlotz, T., Regenbrecht, H., Gray, A., … Inns, S., & Schultz, M. (2020). A noninferiority randomized clinical trail of the use of the smartphone-based health applications IBDsmart and IBDoc in the care of inflammatory bowel disease patients. Inflammatory Bowel Diseases, 26(7), 1098-1109. doi: 10.1093/ibd/izz252
Harvie, R. M., Tuck, C. J., & Schultz, M. (2020). Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: A focus on methane. JGH Open, 4, 198-205. doi: 10.1002/jgh3.12240
Journal - Research Other
Angus, H. C. K., Butt, A. G., Schultz, M., & Kemp, R. A. (2020). Intestinal organoids as a tool for inflammatory bowel disease research. Frontiers in Medicine, 6, 334. doi: 10.3389/fmed.2019.00334
Conference Contribution - Published proceedings: Abstract
Kemp, R., Angus, H., Butt, G., & Schultz, M. (2020). Understanding human Crohn's disease: T cell immunoprofiling and in vitro primary intestinal epithelial monolayer models. Journal of Immunology, 204(1, Suppl.), 224.4. [Abstract]
2019
Journal - Research Article
Lim, M. H., Aluzaite, K., Schultz, M., & Casey, P. (2019). Infliximab trough levels: A comparison between the Quantum Blue Infliximab assay and the established ELISA. Journal of Gastroenterology & Hepatology, 35, 1302-1306. doi: 10.1111/jgh.14964
Aluzaite, K., Al-Mandhari, R., Osborne, H., Ho, C., Williams, M., Sullivan, M.-M., Hobbs, C. E., & Schultz, M. (2019). Detailed multi-dimensional assessment of fatigue in inflammatory bowel disease. Inflammatory Intestinal Diseases, 3(4), 192-201. doi: 10.1159/000496054
Johnson, S., Schultz, M., Scholze, M., Smith, T., Woodfield, J., & Hammer, N. (2019). How much force is required to perforate a colon during colonoscopy? An experimental study. Journal of the Mechanical Behavior of Biomedical Materials, 91, 139-148. doi: 10.1016/j.jmbbm.2018.11.024
Johnson, S., Aluzaite, K., Taar, A., & Schultz, M. (2019). Identifying barriers to treatment of HCV in the primary care setting. Hepatology International, 13, 58-65. doi: 10.1007/s12072-018-9902-x
Barclay, M. L., Karim, S., Helms, E. T. J., Keating, P. E., Hock, B., Stamp, L. K., & Schultz, M. (2019). Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays. Internal Medicine Journal, 49, 513-518. doi: 10.1111/imj.14064
Journal - Research Other
Khan, A., Boyke Berahmana, A., Day, A. S., Barclay, M. L., & Schultz, M. (2019). New Zealand Society of Gastroenterology guidelines on therapeutic drug monitoring in inflammatory bowel disease. New Zealand Medical Journal, 132(1491), 46-62. Retrieved from https://www.nzma.org.nz/journal
Conference Contribution - Published proceedings: Abstract
Aluzaite, K., Wu, H. C.-H., Young, J., Brockway, B., Hyslop, B., & Schultz, M. (2019). Perceived versus objective quality and duration of sleep in long-stay hospital inpatients: Mixed methods study. Sleep Medicine, 64(Suppl. 1), (pp. S13). doi: 10.1016/j.sleep.2019.11.039
Fagan, G., Osborne, H., & Schultz, M. (2019). Compliance with an exercise prescription programme in patients with inflammatory bowel disease in Dunedin, New Zealand. Proceedings of the Sports Medicine New Zealand Annual Conference. (pp. 26). Dunedin, New Zealand: Sports Medicine New Zealand. [Abstract]
Fraser-Miller, S. J., Rooney, J. S., Lau, M., Aluzaite, K., Williams, M., Bolton, A., Schultz, M., & Gordon, K. C. (2019). A multi-spectroscopic approach to disease diagnosis: A proof of principle study for ex vivo detection of coeliac disease. Proceedings of the 12th Annual Dodd-Walls Centre Symposium. (pp. 87). Retrieved from https://www.otago.ac.nz/dodd-walls
Li, K., Wilson, M., Parker, K., Wiles, A., Schultz, M., Slatter, T., Baird, M., & Braithwaite, A. (2019). An Δ133p53-like isoform drives exaggerated immune responses to promote chronic inflammation. European Journal of Immunology, 49(Suppl. 3), (pp. 782). doi: 10.1002/eji.201970400
Walmsley, R., McCombie, A., Barclay, M., Visesio, N., Ho, C., Brown, S., Rosser, K., … Gray, A., Regenbrecht, H., Langlotz, T., & Schultz, M. (2019). A non-inferiority randomised clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc® in the care of inflammatory bowel disease patients. Journal of Crohn's & Colitis, 13(Suppl. 1), (pp. S432-S433). doi: 10.1093/ecco-jcc/jjy222.754
Conference Contribution - Verbal presentation and other Conference outputs
Sharp, K., Schultz, M., & Coppell, K. (2019, September). Non-alcoholic fatty liver disease: The feasibility of two different weight loss dietary approaches. Verbal presentation at the Dietitians New Zealand Conference: Closing the Gap, Auckland, New Zealand.
Schultz, M. (2019, February). Fibre and the gut microbiome. Verbal presentation at the Focus on Fibre & Food Monitoring Symposium, Dunedin, New Zealand.
Other Research Output
Schultz, M. (2019, June). Excuse me, can you show me where the bathroom is? University of Otago, Dunedin, New Zealand. [Inaugural Professorial Lecture].
2018
Journal - Research Article
Coppell, K. J., Galts, C. P.-C., Huizing, F. Y., Norton, J. K., Gray, A. R., Schultz, K., Hobbs, C. E., Aluzaite, K., & Schultz, M. (2018). Annual incidence and phenotypic presentation of IBD in Southern New Zealand: An 18-year epidemiological analysis. Inflammatory Intestinal Diseases, 3(1), 32-39. doi: 10.1159/000492615
Aluzaite, K., Tewhaiti-Smith, J., Fraser, M., Johnson, S., Glen, E., Beck, A., … Dummer, J., & Schultz, M. (2018). A liver health hui: Hepatitis C knowledge and associated risk factors in New Zealand gang members and their families. Royal Society Open Science, 5, 172167. doi: 10.1098/rsos.172167
Hammer, N., Löffler, S., Cakmak, Y. O., Ondruschka, B., Planitzer, U., Schultz, M., … Weise, D. (2018). Cervical vagus nerve morphometry and vascularity in the context of nerve stimulation: A cadaveric study. Scientific Reports, 8(1), 7997. doi: 10.1038/s41598-018-26135-8
Laine, L., Laursen, S. B., Zakko, L., Dalton, H. R., Ngu, J. H., Schultz, M., … Stanley, A. J. (2018). Severity and outcomes of upper gastrointestinal bleeding with bloody vs. coffee-grounds hematemesis. American Journal of Gastroenterology, 113, 358-366. doi: 10.1038/ajg.2018.5
Bahi, M., Walmsley, R. S., Gray, A. R., Young, D., Hobbs, C. E., Aluzaite, K., & Schultz, M. (2018). The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines. Journal of Gastroenterology & Hepatology, 33(5), 1047-1052. doi: 10.1111/jgh.14041
Conference Contribution - Published proceedings: Abstract
Aluzaite, K., Hyslop, B., Barak, Y., Brockway, B., Cutfield, N., & Schultz, M. (2018). Circadian lights in a hospital setting to improve sleep, recovery and decrease psychological distress in older adults. Proceedings of the Australian & New Zealand Society for Sarcopenia & Frality Research (ANZSSFR) Annual Meeting. (pp. 45). Retrieved from https://anzssfr.org/past-meetings
Nichols, G., Dobbs, B., Schultz, M., Barclay, M., & Farella, M. (2018). Simultaneous monitoring of intraoral and oesophageal acidity: Is there an association? European Journal of Orthodontics, 40(5), (pp. e151). doi: 10.1093/ejo/cjy060
Aluzaite, K., Brockway, B., Barak, Y., Hyslop, B., Cutfield, N., & Schultz, M. (2018). Circadian lights in a hospital setting to improve sleep, recovery and decrease psychological distress: Study concept and pilot baseline assessment results. In K. Hillman (Ed.), Proceedings of the 36th International Australasian Winter Conference on Brain Research. (pp. 36). AWCBR. Retrieved from https://www.otago.ac.nz/awcbr
Dummer, J., Cowan, J., Tewhaiti-Smith, J., Aluzaite, K., Fitzgerald, C., & Schultz, M. (2018). Lung health in New Zealand gang members: Results from a health hui. Respirology, 23(Suppl. 1), (pp. 208). doi: 10.1111/resp.13268
Conference Contribution - Verbal presentation and other Conference outputs
Johnson, S., Schultz, M., Scholze, M., Smith, T., Woodfield, J., & Hammer, N. (2018, December). How much force is required to perforate a colon during colonoscopy? Verbal presentation at the 11th Australasian Biomechanics Conference (ABC), Auckland, New Zealand.
Angus, H. C. K., Aluzaite, K., Butt, G. A., Schultz, M., & Kemp, R. A. (2018, August). Novel investigation of Crohn's disease T cell phenotypes and functionality in an in vitro human colonoid model. Verbal presentation at the Queenstown Molecular Biology (QMB) and Australasian Society for Immunology New Zealand Branch (ASI-NZ) Joint Meeting, Queenstown, New Zealand.
Other Research Output
Stebbings, S. & Schultz, M. (2018, July). It takes guts to get arthritis: The spondyloarthritis-Crohn's disease spectrum: A new paradigm? Grand Rounds seminar series, University of Otago, Dunedin, New Zealand. [Department Seminar].
2017
Chapter in Book - Research
Burton, J. P., Chanyi, R. M., & Schultz, M. (2017). Common organisms and probiotics: Streptococcus thermophilus (Streptococcus salivarius subsp. thermophilus). In M. H. Floch, Y. Ringel & W. A. Walker (Eds.), The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. (pp. 165-169). Elsevier. doi: 10.1016/B978-0-12-804024-9.00019-7
Schultz, M., Burton, J. P., & Chanyi, R. M. (2017). Use of Bacillus in human intestinal probiotic applications. In M. H. Floch, Y. Ringel & W. A. Walker (Eds.), The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. (pp. 119-123). Elsevier. doi: 10.1016/B978-0-12-804024-9.00011-2
Schultz, M., & Burton, J. P. (2017). Escherichia coli Nissle 1917. In M. H. Floch, Y. Ringel & W. A. Walker (Eds.), The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. (pp. 59-69). Elsevier. doi: 10.1016/B978-0-12-804024-9.00005-7
Journal - Research Article
Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017). Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World Journal of Gastroenterology, 23(25), 4632-4643. doi: 10.3748/wjg.v23.i25.4632
Schultz, M., Shin, S., & Coppell, K. J. (2017). Awareness of coeliac disease among chefs and cooks depends on the level and place of training. Asia Pacific Journal of Clinical Nutrition, 26(4), 719-724. doi: 10.6133/apjcn.072016.03
Laine, L., Laursen, S. B., Dalton, H. R., Ngu, J. H., Schultz, M., & Stanley, A. J. (2017). Relationship of time to presentation after onset of upper GI bleeding with patient characteristics and outcomes: A prospective study. Gastrointestinal Endoscopy, 86(6), 1026-1037. doi: 10.1016/j.gie.2017.03.1549
Stanley, A. J., Laine, L., Dalton, H. R., Ngu, J. H., Schultz, M., Abazi, R., … on behalf of the International Gastrointestinal Bleeding Consortium. (2017). Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: International multicentre prospective study. BMJ, 356, i6432. doi: 10.1136/bmj.i6432
Tiong, J., Gray, A., Jackson, C., Thompson-Fawcett, M., & Schultz, M. (2017). Audit of the association between length of time spent on diagnostic work-up and tumour stage in patients with symptomatic colon cancer. ANZ Journal of Surgery, 87(3), 138-142. doi: 10.1111/ans.12804
Journal - Research Other
Harvie, R., Chanyi, R. M., Burton, J. P., & Schultz, M. (2017). Using the human gastrointestinal microbiome to personalize nutrition advice: Are registered dietitian nutritionists ready for the opportunities and challenges? Journal of the Academy of Nutrition & Dietetics, 117(12), 1865-1869. doi: 10.1016/j.jand.2016.10.020
Harvie, R., Walmsley, R., Schultz, M., on behalf of the New Zealand Society of Gastroenterology. (2017). “We are what our bacteria eat”: The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions. Journal of Gastroenterology & Hepatology, 32(2), 352-357. doi: 10.1111/jgh.13462
Conference Contribution - Published proceedings: Abstract
Gadeock, S., Schultz, M., & Butt, G. (2017). An inherent defect in tight junction structure and permeability is apparent in colonoids from Crohn's disease patients. FASEB Journal, 31(Suppl. 1), 1043.3. doi: 10.1096/fasebj.31.1_supplement.1043.3
Lim, M. H., Aluzaite, K., Schultz, M., & Casey, P. (2017). Infliximab trough levels: A comparison between the Quantum Blue infliximab rapid assay and the established ELISA. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from http://gastro2017.co.nz
Nuttall, J. W., Aluzaite, K., O'Connor, M., & Schultz, M. (2017). The influence of underlying disease in quality of life in post-ostomy surgery patients. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 72. Retrieved from http://gastro2017.co.nz
Nichols, G., Farella, M., Dobbs, B., Schultz, M., & Barclay, M. (2017). Cross-correlation analysis of intra-oral and esophageal pH in patients with gastro-esophageal reflux disorder (GORD): A pilot study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 56. Retrieved from http://gastro2017.co.nz
McCombie, A., Walmsley, R., Barclay, M., Visesio, N., Ho, C., Brown, S., … Inns, S., & Schultz, M. (2017). Adherence and usability of the smartphone apps IBDsmart and IBDoc©. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 42. Retrieved from http://gastro2017.co.nz
Johnson, S., Tarr, A., & Schultz, M. (2017). Identifying possible barriers to treatment of HCV in the primary care setting. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 26. Retrieved from http://gastro2017.co.nz
Fagan, G., Osborne, H., & Schultz, M. (2017). Fatigue, quality of life, depression and anxiety levels in patients with inflammatory bowel disease (IBD) in Dunedin, New Zealand. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 11. Retrieved from http://gastro2017.co.nz
Fagan, G., Osborne, H., & Schultz, M. (2017). Physical activity levels, attitudes and barriers to exercise of patients with inflammatory bowel disease (IBD) in Dunedin, New Zealand. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 10. Retrieved from http://gastro2017.co.nz
Glen, E., Fraser, M., Pickles, M., Aluzaite, K., Schultz, M., & Johnson, S. (2017). Hepatitis C screening in Southern Otago region and outcomes of an education session. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 9. Retrieved from http://gastro2017.co.nz
Fraser, M., Aluzaite, K., & Schultz, M. (2017). Successful use of generic direct acting antiviral medication to treat hepatitis C in a private practice setting. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 1. Retrieved from http://gastro2017.co.nz
Fraser, M., Tewhaiti-Smith, J., Johnson, S., Al-Mandhari, R., Glen, E., Beck, A., … Aluzaite, K., & Schultz, M. (2017). Hepatitis C knowledge and associated risk factors in New Zealand gang population. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from http://gastro2017.co.nz
Fraser-Miller, S. J., Rooney, J. S., Lau, M., Aluzaite, K., Williams, M., Gordon, K. C., & Schultz, M. (2017). Vibrational spectroscopy for ex vivo detection of coeliac disease: A proof of principle study towards point of care diagnosis. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 54. Retrieved from http://gastro2017.co.nz
Lim, M. H., Aluzaite, K., Schultz, M., & Casey, P. (2017). Infliximab trough levels: A comparison between the Quantum Blue infliximab rapid assay and the established ELISA assay. Journal of Gastroenterology & Hepatology, 32(Suppl. 2), (pp. 132). doi: 10.1111/jgh.13895
Ngu, J. H., Laursen, S. B., Chin, Y. K., Laine, L., Dalton, H. R., Murray, I. A., Schultz, M., … Stanley, A. J. (2017). Performance of upper gastrointestinal bleeding risk assessment scores in variceal bleeding: A prospective international multicenter study. Journal of Hepatology, 66(1 Suppl.), (pp. S380-S381). [Abstract]
Samuel, G., Gadeock, S., Schultz, M., & Butt, G. (2017). The differential response of human epithelial derived colonic organoids to TLR agonists. FASEB Journal, 31(Suppl. 1), 1049.6. doi: 10.1096/fasebj.31.1_supplement.1049.6
Gadeock, S., Schultz, M., & Butt, A. (2017). Increased permeability is an inherent defect in the colonic epithelium of Crohn’s disease patients. New Zealand Medical Journal, 130(1460), (pp. 95-96). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Verbal presentation and other Conference outputs
Schultz, M. (2017, August-September). A whole new world: Gut health and the microbiome. Keynote presentation at the Dietitians NZ National Professional Development Meeting, Wellington, New Zealand.
Schultz, M. (2017, August). Digital technologies to deliver quality IBD care. Verbal presentation at the Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week, Gold Coast, Australia.
Schultz, M. (2017, August). Colonic organoids: Mini guts to study the intestinal epithelium in IBD [Trans-Tasman Lecture]. Plenary presentation at the Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week, Gold Coast, Australia.
Angus, H., Aluzaite, K., Schultz, M., Butt, G., & Kemp, R. (2017, July). Investigation into T cell-mediated Crohn's disease. Verbal presentation at the New Zealand Branch of the Australasian Society for Immunology (NZ ASI) Annual Scientific Meeting, Christchurch, New Zealand.
2016
Journal - Research Article
Kwon, H. J., Dudley-Brown, S., Williams, M., Sullivan, M.-M., & Schultz, M. (2016). Validation of a simple, patient directed, symptom based index for intestinal inflammation. Journal of Clinical Gastroenterology & Treatment, 2(2), 020.
McCombie, A., Langlotz, T., Barclay, M., Walmsley, R., Regenbrecht, H., & Schultz, M. (2016). Systematic review of IBD smartphone apps for symptom monitoring and communication with healthcare professionals. Journal of mHealth, 3(3), 36-41. Retrieved from http://www.thejournalofmhealth.com/
Dunn, E. T. J., Taylor, E. S., Stebbings, S., Schultz, M., Butt, A. G., & Kemp, R. A. (2016). Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation. Immunology & Cell Biology, 94(5), 421-429. doi: 10.1038/icb.2015.112
McRae, K. M., Schultz, M., Mackintosh, C. G., Shackell, G. H., Martinez, M. F., Knowler, K. J., … Ho, C., … McEwan, J. C. (2016). Ovine rumen papillae biopsy via oral endoscopy: A rapid and repeatable method for serial sampling. New Zealand Veterinary Journal, 64(3), 174-178. doi: 10.1080/00480169.2015.1121845
Murray, I. A., Joyce, S., Palmer, J., Lau, M., & Schultz, M. (2016). Incidence and features of eosinophilic esophagitis in dysphagia: A prospective observational study. Scandinavian Journal of Gastroenterology, 51(3), 257-262. doi: 10.3109/00365521.2015.1093166
Conference Contribution - Published proceedings: Abstract
Agarwal, K., Schultz, M., Pianko, S., Bank, L., Collier, J., George, J., … Stace, N., … Foster, G. (2016). Sofosbuvir + peginterferon + ribavirin for 12 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patients with genotype 2 HCV who did not achieve SVR after 16 or 24 weeks of sofosbuvir + ribavirin. Hepatology, 64(Suppl. 1), (pp. 455A-456A). doi: 10.1002/hep.28800
Rodrigues, E., Schultz, M., & Butt, A. G. (2016). Bacteria modulate goblet cell development in the colon: A mechanism compromised in Crohn’s disease. New Zealand Medical Journal, 129(1442), (pp. 97-98). Retrieved from https://www.nzma.org.nz/journal
van Hout, I., Rodrigues, E., Slobbe, L., Schultz, M., & Butt, G. (2016). The effects of bacterial components on colonic stem cell proliferation. New Zealand Medical Journal, 129(1441), (pp. 107-108). Retrieved from http://www.nzma.org.nz/journal
Gadeock, S., Schultz, M., & Butt, G. (2016). TNF-α and IFN-γ induce a biphasic change in the distribution and expression of tight junction proteins in human colonic enteroids. FASEB Journal, 30(1, Suppl.), 1250.2. Retrieved from http://www.fasebj.org/content/30/1_Supplement/1250.2.abstract
Zakko, L., Laursen, S. B., Stanley, A., Dalton, H., Ngu, J. H., Schultz, M., & Laine, L. (2016). Do upper gastrointestinal bleeding scores predict outcomes for patients presenting with hemodynamically significant hematochezia? Gastrointestinal Endoscopy, 83(Suppl. 5), (pp. AB281). doi: 10.1016/j.gie.2016.03.433
Conference Contribution - Poster Presentation (not in published proceedings)
McCombie, A., Langlotz, T., Barclay, M., Walmsley, R., Regenbrecht, H., & Schultz, M. (2016, November). Systematic review of IBD smartphone apps for symptom monitoring and communication with healthcare professionals. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.
2015
Journal - Research Article
Coppell, K. J., Miller, J. C., Gray, A. R., Schultz, M., Mann, J. I., & Parnell, W. (2015). Obesity and the extent of liver damage among adult New Zealanders: Findings from a national survey. Obesity Science & Practice. doi: 10.1002/osp4.13
Schultz, M., Bohwan Seo, S., Holt, A., & Regenbrecht, H. (2015). Family history assessment for colorectal cancer (CRC) risk analysis: Comparison of diagram- and questionnaire-based web interfaces. BMC Medical Informatics & Decision Making, 15, 95. doi: 10.1186/s12911-015-0211-1
Vermunt, J., Fraser, M., Herbison, P., Wiles, A., Schlup, M., & Schultz, M. (2015). Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand. World Journal of Gastroenterology, 21(35), 10224-10233. doi: 10.3748/wjg.v21.i35.10224
Schultz, M., Lai, C. C., Lindstrom, A. L., Stein, K., Donaldson, G., Thompson-Fawcett, M., & Butt, A. G. (2015). Aggravation of established colitis in specific pathogen-free IL-10 knockout mice by restraint stress is not mediated by increased colonic permeability. Journal of Crohn's & Colitis, 9(9), 754-762. doi: 10.1093/ecco-jcc/jjv098
Johnston, M. R., Murray, I. A., Schultz, M., McLeod, P., O'Donnell, N., Norton, H., … García, J. A. (2015). Does preendoscopy Rockall score safely identify low risk patients following upper gastrointestinal haemorrhage? Gastroenterology Research & Practice, 2015, 410702. doi: 10.1155/2015/410702
Laursen, S. B., Dalton, H. R., Murray, I. A., Michell, N., Johnston, M. R., Schultz, M., … on behalf of the Upper Gastrointestinal Hemorrhage International Consortium. (2015). Performance of new thresholds of the Glasgow Blatchford score in managing patients with upper gastrointestinal bleeding. Clinical Gastroenterology & Hepatology, 13(1), 115-121. doi: 10.1016/j.cgh.2014.07.023
Journal - Research Other
Hendry, K., Glue, P., Hill, J., & Schultz, M. (2015). Ingestion of sharp foreign objects: A case series, literature review and management recommendation [Case review]. Journal of Gastric Disorders & Therapy, 1(1). doi: 10.16966/jgdt.101
Journal - Professional & Other Non-Research Articles
Eliadou, E., Day, A. S., Thompson-Fawcett, M., Gearry, R. B., Rowbotham, D. S., Walmsley, R., Schultz, M., Inns, S. J., on behalf of IBDNZ. (2015). New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis. New Zealand Medical Journal, 128(1423), 63-76. Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Published proceedings: Abstract
Galts, C., Huinzing, F., Gray, A., Norton, J., Coppell, K., & Schultz, M. (2015). Annual incidence of IBD in Otago, New Zealand: An 18-year epidemiological analysis. Journal of Crohn's & Colitis, 9(Suppl. 1), (pp. S418-S419). doi: 10.1093/ecco-jcc/jju027.791
Rodrigues, E., Slobbe, L., Schultz, M., & Butt, G. (2015). Chronic exposure to microbial stimuli affects the development of the intestinal epithelium in human colonic enteroids. FASEB Journal, 29(1, Suppl.), 999.7. Retrieved from http://www.fasebj.org/content/29/1_Supplement/999.7.abstract
Conference Contribution - Poster Presentation (not in published proceedings)
van Hout, I., Rodrigues, E., Slobbe, L., Schultz, M., & Butt, A. G. (2015, August-September). Modulation of colonic stem cell proliferation by bacterial components. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Sharp, K. P. H., Coppell, K. J., & Schultz, M. (2015, August-September). Review: What dietary components trigger hepatic fat accumulation in Non-Alcoholic Fatty Liver Disease (NAFLD)? Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Samuel, G., Rodrigues, E., Slobbe, L., Schultz, M., & Butt, A. G. (2015, August-September). The expression of functional toll like receptors in human colonic organoids. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Rodrigues, E., Slobbe, L., Samuel, G., Gadeock, S., Schultz, M., & Butt, A. G. (2015, August-September). Chronic exposure to LPS modified lineage development via the TLR4 dependent pathway in human colonic enteroids. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Gadeock, S., Schultz, M., & Butt, A. G. (2015, August-September). TNF-α induces a biphasic change in the expression and distribution of tight junction proteins in human colonic enteroids. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Schultz, M. (2015, August-September). The pathogenesis of IBD. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.
Schultz, M., & Wild, L. (2015, November). Skin cancer screening in patients on immunomodulators. Workshop presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Section Annual Scientific Meeting, Rotorua, New Zealand.
Schultz, M. (2015, November). Fatigue in inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Section Annual Scientific Meeting, Rotorua, New Zealand.
2014
Journal - Research Article
Schultz, H., Higham, J., & Schultz, M. (2014). The informal caregiver: A qualitative assessment of needs and requirements. Family Medicine & Medical Science Research, 3(4), 144. doi: 10.4172/2327-4972.1000144
Dyke, J., Hendry, K., Hill, J., Schultz, M., Mason, E., & Glue, P. (2014). Management of a cluster of foreign body ingestion incidents in patients with borderline personality disorder. Open Journal of Psychiatry, 4, 99-103. doi: 10.4236/ojpsych.2014.42014
Thomas, G. R., Lewis-Morris, T., Rowbotham, D., Whiteside, C., Joyce, S., Inns, S., Schultz, M., & Gearry, R. B. (2014). Adalimumab for Crohn’s disease in New Zealand: A prospective multicentre experience. New Zealand Medical Journal, 127(1396). Retrieved from http://www.nzma.org.nz/journal
Kini, G. P., Schultz, M., Herbison, P., & Young, B. (2014). Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn’s disease? New Zealand Medical Journal, 127(1394). Retrieved from http://www.nzma.org.nz/journal
Tarr, G. P., Crowley, A., John, R., Kok, J. B., Lee, H.-N. L., Mustafa, H., Sii, K. M., Smith, R., Son, S.-E. Q., Weaver, L. J., Cameron, C., Dockerty, J. D., Schultz, M., & Murray, I. A. (2014). Do high risk patients alter their lifestyle to reduce risk of colorectal cancer? BMC Gastroenterology, 14(1), 22. doi: 10.1186/1471-230X-14-22
Conference Contribution - Published proceedings: Full paper
Regenbrecht, H., Langlotz, T., Ho, C., George, M., Gray, A., Walmsley, R., & Schultz, M. (2014). Field test of a questionnaire-based mobile health reporting system. In T. Robertson, K. O'Hara, G. Wadley, L. Loke & T. Leong (Eds.), Proceedings of the 26th Australian Computer-Human Interaction (OzCHI) Conference on Designing Futures: the Future of Design. (pp. 384-387). New York: ACM. doi: 10.1145/2686612.2686670
Conference Contribution - Published proceedings: Abstract
Nolan, A., Roberts, R. L., Wallace, M. C., Pearson, J., van Rij, A., Jones, G. T., Jackson, P. M., Schultz, M. P., Day, A. S., & Gearry, R. B. (2014). Genetic association of oral Crohn disease with intestinal Crohn disease. Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology, 117(5), (pp. e347). doi: 10.1016/j.oooo.2014.01.072
Barclay, M. L., Helms, E., Hock, B., Schultz, M., & Stamp, L. K. (2014). Trough concentrations of infliximab and adalimumab, and anti-drug antibodies, correlate with drug response in inflammatory bowel disease. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 25). Retrieved from http://www.asceptasm.com/
Schultz, M. (2014). Commercial research as an alternative funding source for investigator-led research. Proceedings of the New Zealand Association of Clinical Research 10 Anniversary Conference. Retrieved from http://www.nzacres2014.org.nz/
Fan, S., Schultz, M., & Butt, G. (2014). Inflammation reduces the activity of the NaHCO3 cotransporter, NBCe1, in the surface cells of the proximal colon of IL10 knockout mice. FASEB Journal, 28(1, Suppl.), 908.1. [Abstract]
Rodrigues, E., Slobbe, L., Schultz, M., & Butt, G. (2014). Spontaneous maturation of human colonic organoids. FASEB Journal, 28(1, Suppl.), 1119.2. [Abstract]
Conference Contribution - Poster Presentation (not in published proceedings)
Rodrigues, E., Slobbe, L., Schultz, M., & Butt, A. G. (2014, November). Chronic exposure to LPS induces goblet cell differentiation in human colonic organoids. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Gadeock, S., Schultz, M., & Butt, G. (2014, November). Colonoids: A model of the colonic epithelium in IBD. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Samuel, M., Rodrigues, E., Slobbe, L., Schultz, M., & Butt, G. (2014, November). The expression of toll like receptors in human colonic organoids, three-dimensional cultures of the colonic epithelium. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Fan, L., Schultz, M., & Butt, G. (2014, November). Inflammation reduces the activity of the NaHCO3 cotransporter, NBCe1, in the surface cells of the proximal colon of IL10-/- mice. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Braun, J., Keenan, J., Schultz, M., & Butt, G. (2014, November). Polarization of Caco2 cells impedes uptake of outer membrane vesicles. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Khan, A., Parslow, G., Smith, G., & Schultz, M. (2014, November). Use of faecal calprotectin in Otago and its effect on patient management. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Lim, M. H., Schultz, M., & Hill, J. (2014, November). Have you considered intestinal spirochaetosis? Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Kenrick, K., Schultz, M., Day, A., & Jaye, C. (2014, November). Coeliac disease conundrums: A survey of NZ gastroenterologists. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Ho, C., Walmsley, R., Gray, A., Langlotz, T., Regenbrecht, H., Barclay, M., & Schultz, M. (2014, November). IBDsmart: The usability and acceptance of mobile media in the monitoring of patients with IBD. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Lim, M. H., Phipps-Green, M., Merriman, T., & Schultz, M. (2014, November). Associations of NOD2 mutations with disease phenotype in an Otago cohort of patients with Crohn's disease. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Gadeock, S., Schultz, M., & Butt, G. (2014, November). Colonoids: A model of the colonic epithelium in IBD? Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Galts, C., Fokko, H., Norton, J., Gray, A., Coppell, K., & Schultz, M. (2014, November). Annual incidence of IBD in the Otago region: An 18-year epidemiological analysis. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Barclay, M. L., Helms, E., Hock, B., Stamp, L. K., & Schultz, M. (2014, November). Infliximab and adalimumab trough concentrations and anti-drug antibodies correlate with response in inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
Rodrigues, E., Slobbe, L., Schultz, M., & Butt, A. G. (2014, November). Chronic exposure to LPS induces goblet cell differentiation in human colonic organoids. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.
2013
Journal - Research Article
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., … for the GEMINI 2 Study Group, including Gearry, R., Schultz, M., & Wyeth, J. (2013). Vedolizumab as induction and maintenance therapy for Crohn's disease. New England Journal of Medicine, 369(8), 711-721. doi: 10.1056/NEJMoa1215739
Schultz, M., Dunn, E., Taylor, E., Butt, G. A., & Kemp, R. (2013). The Gut Map Project: T cell distribution in inflammation of the gut. Journal of Gastroenterology & Hepatology, 28(Suppl. 3), 588. doi: 10.1111/jgh.12363_2
Tarr, G. P., Smith, R. A., John, R. A., Crowley, A. P., Kok, J. B. C., Lee, H.-N., Mustafa, M. H. B., Sii, K. M., Son, S.-E., Weaver, L. J., Cameron, C., Dockerty, J. D., Murray, I. A., & Schultz, M. (2013). Perceived risks and benefits of surveillance colonoscopy in people undergoing surveillance for family history of colorectal cancer. New Zealand Medical Journal, 126(1382). Retrieved from http://www.nzma.org.nz/journal
Kemp, R., Dunn, E., & Schultz, M. (2013). Immunomodulators in inflammatory bowel disease: An emerging role for biologic agents. BioDrugs, 27(6), 585-590. doi: 10.1007/s40259-013-0045-2
Kini, G. P., Murray, I., Champion-Young, J., Lau, M., Katta, V., Thorn, M., & Schultz, M. P. (2013). Cap polyposis mistaken for Crohn's disease: Case report and review of literature. Journal of Crohn's & Colitis, 7(3), e108-e111. doi: 10.1016/j.crohns.2012.06.005
Journal - Research Other
Kini, G. P., McAlindon, M. E., Schultz, M., Collett, J., & Murray, I. A. (2013). Gastrointestinal: Capsule endoscopy of a very refractory celiac disease. Journal of Gastroenterology & Hepatology, 28(8), 1254. doi: 10.1111/jgh.12298
Conference Contribution - Published proceedings: Full paper
Taylor, J., Bekhit, A. E. D., Schultz, M., & Chandraratne, M. R. (2013). Effect of tempeh addition on in vitro oxidative processes during the digestion of beef patties. In M. Serdaroğlu, B. Öztürk & T. Ackan (Eds.), Proceedings of the 59th International Congress of Meat Science and Technology (ICoMST). Retrieved from http://icomst2013.org/t/e-book/index.html
Conference Contribution - Published proceedings: Abstract
Dunn, E., Taylor, E., Schultz, M., Butt, G., & Kemp, R. (2013). Macrophage and T cell distribution in autoimmune inflammation of the gut. Proceedings of the 43rd Australasian Society for Immunology (ASI) Annual Scientific Meeting. (pp. 86). Retrieved from http://www.asi2013.org/
Coppell, K. J., Miller, J., Schultz, M., Gray, A., Mann, J. I., & Parnell, W. (2013). The prevalence of abnormal liver enzymes in New Zealand: Findings from the 2008/09 Adult Nutrition Survey. New Zealand Medical Journal, 126(1387). Retrieved from http://www.nzma.org.nz/journal
Dunn, E., Taylor, E., Stebbings, S., Schultz, M., Butt, G., & Kemp, R. (2013). T cell distribution in gastrointestinal inflammatory disorders. New Zealand Medical Journal, 126(1387). Retrieved from http://www.nzma.org.nz/journal
Harvie, R., Chisholm, A., & Schultz, M. (2013). A reduction in FODMAP intake correlates strongly with a reduction in IBS symptoms: The FIBS study. New Zealand Medical Journal, 126(1387). Retrieved from http://www.nzma.org.nz/journal
Rodrigues, E., Slobbe, L., Schultz, M., & Butt, G. (2013). Spontaneous maturation of organoids grown from isolated human colonic biopsies. New Zealand Medical Journal, 126(1387). Retrieved from http://www.nzma.org.nz/journal
Schultz, M., Harvie, R., & Chisholm, A. (2013). A reduction in FODMAP intake correlates strongly with a reduction in IBS symptoms: The FIBS study. Journal of Gastroenterology & Hepatology, 28(Suppl. 3), (pp. 352-353). doi: 10.1111/jgh.12363_2
Murray, I. A., Bennett, S., Palmer, J., Lau, M., & Schultz, M. (2013). Incidence and predictors of eosinophilic oesophagitis in dysphagia: A prospective analysis. Gut, 62(Suppl. 1), (pp. A107-107). doi: 10.1136/gutjnl-2013-304907.236
Murray, I. A., Lee, A., Tan, C., Lau, M., Palmer, J., & Schultz, M. (2013). Incidence of eosinophilic oesophagitis in a New Zealand population: A retrospective analysis. Gut, 62(Suppl. 1), (pp. A107-107). doi: 10.1136/gutjnl-2013-304907.235
Murray, I. A., Johnston, M. R., Leung, H., Norton, H., Park, J.-Y., Fesaitu, T., Baines, C., Fawcett, E., Salleh, A., McLeod, P., O'Donnell, N. R., Zhang, W., García, J. A., & Schultz, M. (2013). Does Glasgow Blatchford score or pre-endoscopy Rockall score identify low risk patients following upper gastrointestinal haemorrhage? A New Zealand perspective. Gut, 62(Suppl. 1), (pp. A271). doi: 10.1136/gutjnl-2013-304907.635
Murray, I. A., Tarr, G. P., John, R., Crowley, A., Kok, J., Mustafa, H., Lee, H.-N., Weaver, L., Smith, R., Son, Q., Sii, K. M., Cameron, C., Dockerty, J., & Schultz, M. (2013). Changing lifestyle to reduce colorectal cancer in a high risk population. Gut, 62(Suppl. 1), (pp. A138). doi: 10.1136/gutjnl-2013-304907.311
Fan, S., Schultz, M., & Butt, G. (2013). Inflammation reduces the response to forskolin and expression of the NaHCO3 cotransporter, NBCe1, in the proximal colon of IL10-/- mice. FASEB Journal, 27(Meeting Abstract Suppl.), 949.6. [Abstract]
Dunn, E., Kemp, R., Schultz, M., & Butt, G. (2013). Long-term in vitro expansion of human intestinal organoids. New Zealand Medical Journal, 126(1374). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Poster Presentation (not in published proceedings)
Bahi, M., Schultz, M., Walmsley, R., & Young, D. (2013, September). Skin cancer in IBD patients treated with immunomodulators. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.
Dunn, E., Taylor, E., Schultz, M., Butt, G., & Kemp, R. (2013, September). Macrophage and T cell distribution in autoimmune inflammation of the gut. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Schultz, M. (2013, November). Reducing colon cancer risk with drugs. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Wellington, New Zealand.
Schultz, M. (2013, December). The Gut Health Network in its second year: It all starts in the gut! Verbal presentation at the University of Otago Triple Theme Research Meeting: The Kidney in Health and Disease, Gut Health Network, Arthritis Research, Dunedin, New Zealand.
2012
Journal - Research Article
Pan, A., Schlup, M., Lubcke, R., Chou, A., & Schultz, M. (2012). The role of aspirin in post-polypectomy bleeding: A retrospective survey. BMC Gastroenterology, 12, 138. doi: 10.1186/1471-230X-12-138
Stebbings, S., Jenks, K., Treharne, G. J., García, J. A., Schultz, M., Highton, J., & Dudley-Brown, S. (2012). Validation of the Dudley Inflammatory Bowel Symptom Questionnaire for the assessment of bowel symptoms in axial SpA: Prevalence of clinically relevant bowel symptoms and association with disease activity. Rheumatology, 51(5), 858-865. doi: 10.1093/rheumatology/ker359
Journal - Research Other
Schultz, M., & Butt, A. G. (2012). Is the north to south gradient in inflammatory bowel disease a global phenomenon? Expert Review of Gastroenterology & Hepatology, 6(4), 445-447. doi: 10.1586/egh.12.31
Coffey, S., Nadarasa, K., Pan, A., van der Linden, A., Chu, J., & Schultz, M. (2012). The increasing incidence of Streptococcus bovis endocarditis and bacteraemia: A case series from 1997 to 2010. International Journal of Cardiology, 161(2), 111-113. doi: 10.1016/j.ijcard.2012.06.031
Conference Contribution - Published proceedings: Abstract
Lindstrom, A., Fan, S., Schultz, M., & Butt, G. (2012). The effect of Helicobacter typhlonius infection on colonic ion transport in the IL10 knockout mice. FASEB Journal, 26(Meeting Abstract Suppl.), 1109.1. [Abstract]
Schultz, M., Lewis-Morris, T., Rowbotham, D., Whiteside, C., Bennett, S., Thomas, G., Inns, S., & Gearry, R. B. (2012). Outcomes of adalimumab therapy for Crohn's disease from five New Zealand hospitals. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal
Dunn, E., Taylor, E., Schultz, M., Butt, G., & Kemp, R. (2012). Macrophage and T cell distribution in autoimmune inflammation of the gut. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal
Conference Contribution - Poster Presentation (not in published proceedings)
Taylor, J., Bekhit, A. E.-D., & Schultz, M. (2012, June). Effect of tempeh addition on in vitro oxidative processes during the digestion of beef patties. Poster session presented at the New Zealand Institute of Food Science & Technology Inc (NZIFST) Conference: Let's Talk: Co-operation, Collaboration, Communication, Hamilton, New Zealand.
2011
Journal - Research Article
Pan, A., Schlup, M., Lubcke, R., & Schultz, M. (2011). Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: A case report and literature review. Journal of Crohn's & Colitis, 5(5), 465-468. doi: 10.1016/j.crohns.2011.04.011
Schultz, M., Baranchi, A., Thurston, L., Yu, Y. C., Wang, L., Chen, J., Sapsford, M., Chung, J., Binsadiq, M., Craig, L., Wilkins, B., McBride, D., & Herbison, P. (2011). Consumer demographics and expectations of probiotic therapy in New Zealand: Results of a large telephone survey. New Zealand Medical Journal, 124(1329). Retrieved from http://journal.nzma.org.nz/journal/124-1329/4537/content.pdf
Tannock, G. W., Tiong, I. S., Priest, P., Munro, K., Taylor, C., Richardson, A., & Schultz, M. (2011). Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. Journal of Medical Microbiology, 60(3), 366-370. doi: 10.1099/jmm.0.025874-0
Journal - Research Other
Pan, A., Doyle, T., Schlup, M., Lubcke, R., & Schultz, M. (2011). Unusual manifestation of Erdheim-Chester disease. BMC Gastroenterology, 11, 77. doi: 10.1186/1471-230x-11-77
Conference Contribution - Published proceedings: Abstract
Stebbings, S., Jenks, K., García, J. A., Schultz, M., Highton, J., & Dudley-Brown, S. (2011). Assessing bowel symptoms in axial spondyloarthritis: A high prevalence of clinically relevant bowel symptoms and a correlation with disease activity. Annals of the Rheumatic Diseases, 70(Suppl. 3), (pp. 519). [Abstract]
Braun, J. H., Butt, A. G., Keenan, J. I., & Schultz, M. (2011). Outer membrane vesicles (OMV) from intestinal bacteria as means of communication: Comparison of the effects of OMV from three different Escherichia coli strains on intestinal epithelial cells in vitro. New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf
Lindstrom, A. L., Donaldson, G., Butt, A. G., & Schultz, M. (2011). Helicobacter typhlonius triggers colitis in IL10-/- mice without increasing intestinal permeability. New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf
Pan, A., Alansari, M., Lubcke, R., Williams, M., Fraser, M., Buckingham, S., & Schultz, M. (2011). Use of pethidine for percutaneous liver biopsy. New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf
Conference Contribution - Poster Presentation (not in published proceedings)
Taylor, J., Bekhit, A. E.-D., & Schultz, M. (2011, November). Effect of tempeh addition on in vitro oxidative processes during the digestion of beef patties. Poster session presented at the Functional Foods Symposium: Foods for Health & Wellness: Perspectives for Industry, Auckland, New Zealand.
Taylor, J., Bekhit, A. E.-D., & Schultz, M. (2011, November). Effect of tempeh addition on in vitro oxidative processes during the digestion of beef patties. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Schultz, M. (2011, November). Small intestinal lesions in patients with Spondyloarthropathies. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand.
2010
Journal - Research Article
Stebbings, S., Jenks, K., Roberts, R., & Schultz, M. (2010). The immune response to gut bacteria in spondyloarthritis: A role in pathogenesis? Journal of Clinical Rheumatology & Musculoskeletal Medicine, 1(2).
Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P., & Highton, J. (2010). Probiotic therapy for the treatment of spondyloarthritis: A randomized controlled trial. Journal of Rheumatology, 37(10), 2118-2125. doi: 10.3899/jrheum.100193
Schultz, M., & Butt, G. (2010). E. coli Nissle 1917 in the treatment of inflammatory bowel disease. Practical Gastroenterology, 34(3), 11-19.
Schultz, M., Gearry, R., Walmsley, R., Day, A. S., Fraser, A., Wyeth, J., Barclay, M., … Whiteside, C. (2010). New Zealand Society of Gastroenterology statement on the use of biological therapy in inflammatory bowel disease. New Zealand Medical Journal, 123(1314). Retrieved from http://journal.nzma.org.nz/journal/123-1314/4115/content.pdf
Journal - Research Other
Schultz, M., Roberts, R. L., & Butt, A. G. (2010). Understanding probiotic treatment strategies in inflammatory bowel disease, with a special emphasis on the intestinal barrier. European Gastroenterology & Hepatology Review, 6(1), 58-65.
Conference Contribution - Published proceedings: Abstract
Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P., & Highton, J. (2010). Probiotic therapy for the treatment of spondyloarthritis: A randomised controlled trial. Annals of the Rheumatic Diseases, 69(Suppl. 3), (pp. 261). [Abstract]
Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P., & Highton, J. (2010). Probiotic therapy for spondyloarthritis: A randomised controlled trial. Internal Medicine Journal. 40(Suppl. 3), (pp. 3). doi: 10.1111/j.1445-5994.2010.02234.x
Roberts, R. L., Gearry, R. B., Barclay, M. L., Hollis-Moffatt, J. E., Merriman, T. R., Jenks, K., Schultz, M., & Stebbings, S. (2010). Specific Interleukin-23 receptor haplotype may confer protection against Crohn's disease while increasing risk of Spondyloarthritis. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Tiong, J., Jackson, C., Schlup, M., Lubcke, R., & Schultz, M. (2010). Advanced tumour stages do not correlate with therapeutic delay in colonic cancer. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Coffey, S., Nadarasa, K., Pan, A., van der Linden, A., Chu, J., & Schultz, M. (2010). Streptococcus bovis bacteraemia in Dunedin Hospital from 1997 to 2009: A case series. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Lai, C., Lindstrom, A., Thompson-Fawcett, M., Butt, A., & Schultz, M. (2010). Psychological stress exacerbates colitis in interleukin-10 knockout mice. New Zealand Medical Journal. 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4493/content.pdf
Lindstrom, A. L., Myllyluoma, E., Donaldson, G., Butt, A. G., & Schultz, M. (2010). Limited effectiveness of three different probiotics on mild colitis in IL10-/- mice. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Kwon, H. J., Schlup, M., Lubcke, R., Dudley-Brown, S., & Schultz, M. (2010). Validation of a short quality of life questionnaire in Inflammatory Bowel Disease. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf
Conference Contribution - Verbal presentation and other Conference outputs
Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P., & Highton, J. (2010, August). Probiotic therapy for spondyloarthritis: A randomised controlled trial. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.
2009
Journal - Research Article
Schultz, M., Davidson, A., Donald, S., Targonska, B., Turnbull, A., Weggery, S. E., Livingstone, V., & Dockerty, J. D. (2009). Gastroenterology service in a teaching hospital in rural New Zealand, 1991-2003. World Journal of Gastroenterology, 15(5), 583-590. doi: 10.3748/wjg.15.583
Conference Contribution - Published proceedings: Abstract
Stebbings, S. M., Schultz, M., Dudley-Brown, S., & Highton, J. (2009). The severity of bowel symptoms is similar in active ankylosing spondylitis and Crohn's disease. Annals of the Rheumatic Diseases, 68(Suppl. 3), (pp. 649). [Abstract]
Lai, C. C., Lindstrom, A. L., Thompson-Fawcett, M., Schultz, M., & Butt, A. G. (2009). The effects of chronic psychological stress on intestinal inflammation and permeability in IL-10 deficient mice. Proceedings of the ComBio2009 Conference. [CD-ROM] [Abstract]
Lindstrom, A. L., Lai, C. C., Schultz, M., & Butt, A. G. (2009). Indomethacin causes early onset of severe colitis in IL10-/- mice in the absence of increased intestinal permeability. Proceedings of the ComBio2009 Conference. [CD-ROM] [Abstract]
Stebbings, S., Schultz, M., Dudley-Brown, S., & Highton, J. (2009). Bowel symptoms are similar in Ankylosing spondylitis and Crohn's Disease and reflect disease activity. Internal Medicine Journal. 39(Suppl. 2), (pp. A41). doi: 10.1111/j.1445-5994.2009.01951_1.x
Conference Contribution - Poster Presentation (not in published proceedings)
Stebbings, S., Schultz, M., Dudley-Brown, S., & Highton, J. (2009, November). The Dudley Inflammatory Bowel Symptom Questionnaire demonstrates similar severity of bowel symptoms in Ankylosing spondylitis and Crohn's Disease in remission. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Bohwan Seo, S., Holt, A., & Schultz, M. (2009, September-October). Usability evaluation of web based family history assessment tool for colorectal cancer (CRC) risk analysis. Verbal presentation at the Health Informatics New Zealand (HINZ) 8th Annual Conference: Person Centred Healthcare: eHealth as an Enabler, Rotorua, New Zealand.
2008
Chapter in Book - Research
Schultz, M. (2008). Escherichia coli. In J. Versalovic & M. Wilson (Eds.), Therapeutic microbiology: Probiotics and related strategies. (pp. 83-96). Washington, DC: ASM Press.
Journal - Research Article
Schultz, M., & Lindström, A. L. (2008). Rationale for probiotic treatment strategies in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology, 2(3), 337-355. doi: 10.1586/17474124.2.3.337
Howard, R., Karageorge, G., van Harselaar, K., Bell, M., Basford, P., Schultz, M., & Derrett, S. (2008). Post-procedure surveillance in liver biopsy: How long is long enough? New Zealand Medical Journal, 121(1280). Retrieved from http://journal.nzma.org.nz/journal/121-1280/3219/content.pdf
Schultz, M. (2008). Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflammatory Bowel Diseases, 14(7), 1012-1018.
Switzer-Taylor, V., Schlup, M., Lübcke, R., Livingstone, V., & Schultz, M. (2008). Barrett's esophagus: A retrospective analysis of 13 years surveillance. Journal of Gastroenterology & Hepatology, 23(9), 1362-1367.
Journal - Professional & Other Non-Research Articles
Schultz, M., & Butt, G. (2008). Probiotic therapy in Inflammatory Bowel Disease: Why they should work! Probiotica, 24, 4-6.
Schultz, M., & Gearry, R. B. (2008). [Independent commentary of published medical research]. IBD Research Review, (1). Retrieved from http://www.researchreview.co.nz/research_review_catalogue.cfm?ID=40
Conference Contribution - Verbal presentation and other Conference outputs
Lindstrom, A. L., Myllyluoma, E., Donaldson, G., Schultz, M., & Butt, A. G. (2008, November). Increased intestinal permeability does not precede mild colitis in the IL10-/- mouse model of inflammatory bowel disease. Verbal presentation at the Medical Sciences Congress, Queenstown, New Zealand.
Schultz, M. (2008, November). Mechanisms of increased intestinal permeability in chronic disorders: Common ground for intervention? Verbal presentation at the Medical Sciences Congress, Queenstown, New Zealand.
2007
Journal - Research Article
Schultz, M., & Butt, A. G. (2007). Methodological aspects in probiotic research: A brief review with an emphasis on epithelial barrier function. International Journal of Probiotics & Prebiotics, 2(2/3), 85-96.
Conference Contribution - Published proceedings: Abstract
van Harselaar, K., Howard, R., Cammack, I., Colbourne, L., Hamilton, M., Karageorge, G., Kong, V., La Hood, B., Derrett, S., Bell, M., Lubcke, R., Schlup, M., … Schultz, M. (2007). The rate of complications in elective percutaneous liver biopsies: A retrospective analysis of over 450 consecutive procedures. New Zealand Medical Journal, 120(1266). Retrieved from http://journal.nzma.org.nz/journal/120-1266/2848/content.pdf
Conference Contribution - Verbal presentation and other Conference outputs
Schultz, M. (2007, August-September). Inflammatory bowel disease and the spondyloarthropthies. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.
van Harselaar, K., Howard, R., Cammack, I., Colbourne, L., Hamilton, M., Karageorge, G., Kong, V., La Hood, B., Derrett, S., Bell, M., Lubcke, R., Schlup, M., … Schultz, M. (2007, November). The rate of complications in elective percutaneous liver biopsies: A retrospective analysis of over 450 consecutive procedures. Verbal presentation at the New Zealand Society of Gastroenterology Annual Scientific Meeting, Christchurch, New Zealand.
2006
Journal - Research Article
McBurney, W., Mangold, M., Munro, K., Schultz, M., Rath, H. C., & Tannock, G. W. (2006). PCR/DGGE and 16S rRNA gene library analysis of the colonic microbiota of HLA-B27/β2-microglobulin transgenic rats. Letters in Applied Microbiology, 42, 165-171.
2005
Journal - Research Article
Schultz, M. (2005). Celiac disease: More common than previously assumed. AESKU.SCIENCE, 2(October), 3-9.
Schultz, M., Watzl, S., Oelschlaeger, T. A., Rath, H. C., Göttl, C., Lehn, N., … Linde, H.-J. (2005). Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo. Journal of Microbiological Methods, 61, 389-398.
Strauch, U. G., Obermeier, F., Grunwald, N., Gürster, S., Dunger, N., Schultz, M., … Rath, H. C. (2005). Influence of intestinal bacteria on induction of regulatory T cells: Lessons from a transfer model of colitis. Gut, 54, 1546-1552. Retrieved from http://gut.bmjjournals.com
Conference Contribution - Published proceedings: Abstract
Schultz, M., Weggery, S., Dockerty, J., Ross, H., Luebcke, R., & Schlup, M. (2005). Change in prevalence of GI diseases in the Otago region investigated over a 12-year period. Proceedings of the New Zealand Society of Gastroenterology and NZNO Gastroenterology Nurses Section Annual Scientific Meeting. (pp. 95). Auckland, New Zealand: Medical Industry Association of New Zealand. [Abstract]
2004
Journal - Research Article
Schultz, M., Timmer, A., Herfarth, H. H., Sartor, R. B., Vanderhoof, J. A., & Rath, H. C. (2004). Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterology, 4(5). Retrieved from http://www.biomedcentral.com/content/pdf/1471-230X/4/5.pdf
Gerbitz, A., Schultz, M., Wilke, A., Linde, H.-J., Schölmerich, J., Andreesen, R., & Holler, E. (2004). Probiotic effects on experimental graft-versus-host disease: Let them eat yogurt. Blood, 103(11), 4365-4367.
Schultz, M., Schölmerich, J., & Kullmann, F. (2004). Management of chemotherapy-induced diarrhea. Zeitschrift für Gastroenterologie, 42(6), 527-538.
Schultz, M., Göttl, C., Young, R. J., Iwen, P., & Vanderhoof, J. A. (2004). Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. Journal of Pediatric Gastroenterology & Nutrition, 38(3), 293-297.
Schultz, M., Strauch, U. G., Linde, H.-J., Watzl, S., Obermeier, F., Göttl, C., … Rath, H. C. (2004). Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clinical & Diagnostic Laboratory Immunology, 11(2), 372-378.
Schultz, M., Munro, K., Tannock, G. W., Melchner, I., Göttl, C., Schwietz, H., … Rath, H. C. (2004). Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clinical & Diagnostic Laboratory Immunology, 11(3), 581-587.
2003
Journal - Research Article
Schultz, M., Schölmerich, J., & Rath, H. C. (2003). Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Digestive Diseases, 21(2), 105-128.
Schultz, M., Linde, H.-J., Lehn, N., Zimmermann, K., Grossmann, J., Falk, W., & Schölmerich, J. (2003). Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. Journal of Dairy Research, 70(2), 165-173.
Grossmann, J., Walther, K., Artinger, M., Kiessling, S., Steinkamp, M., Schmautz, W.-K., … Schultz, M., … Rogler, G. (2003). Progress on isolation and short-term ex-vivo culture of highly purified non-apoptotic human intestinal epithelial cells (IEC). European Journal of Cell Biology, 82, 262-270.
von Landenberg, P., Matthias, T., Zaech, J., Schultz, M., Lorber, M., Blank, M., & Shoenfeld, Y. (2003). Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. American Journal of Reproductive Immunology, 49, 51-56.
2002
Chapter in Book - Research
Schultz, M., & Rath, H. C. (2002). The possible role of probiotic therapy in inflammatory bowel disease. In G. W. Tannock (Ed.), Probiotics and prebiotics: Where are we going? (pp. 175-238). Caister Academic Press.
Journal - Research Article
Schultz, M., & Hellerbrand, C. (2002). Viele Fälle bleiben unerkannt. Deutsches Ärzteblatt, 99, 28-29.
Schultz, M., Hartmann, A., Dietmaier, W., Woenckhaus, M., & Lock, G. (2002). Massive steatosis hepatis: An unusual manifestation of Whipple's disease. American Journal of Gastroenterology, 97(3), 771-772.
Schultz, M., Veltkamp, C., Dieleman, L. A., Grenther, W. B., Wyrick, P. B., Tonkonogy, S. L., & Sartor, R. B. (2002). Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflammatory Bowel Diseases, 8(2), 71-80.
2001
Journal - Research Article
Schultz, M., Clarke, S. H., Arnold, L. W., & Sartor, R. B. (2001). Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology, 104(2), 127-134.
Rath, H. C., Schultz, M., Freitag, R., Dieleman, L. A., Li, F., Linde, H.-J., … Sartor, R. B. (2001). Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infection & Immunity, 69(4), 2277-2285.
2000
Conference Contribution - Published proceedings: Full paper
Schultz, M., & Sartor, R. B. (2000). Probiotics and inflammatory bowel diseases. The American Journal of Gastroenterology. 95(1), (pp. S19-S21). [Full Paper]